Analysis of combination therapy of immune checkpoint inhibitors in osteosarcoma

Analysis of combination therapy of immune checkpoint inhibitors in osteosarcoma

One of the most common primary bone malignant tumors is osteosarcoma (OS), possessing a high tendency of local invasion and distant metastasis. Although surgery combined with chemotherapy can extend the patients’ survival time, the prognosis for most patients with metastases or relapses is poor. Imm...

Full description

Bibliographic Details
Main Authors: Lijun Peng, Huapan Fang, Xiao Yang, Xi Zeng
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Chemistry
Subjects:
immunotherapy
PD-1
PD-L1
CTLA-4
sarcoma
osteosarcoma
Online Access:https://www.frontiersin.org/articles/10.3389/fchem.2022.847621/full

Similar Items

Similar Items